ARCHIVES

In Brief: NVI Delays Release Of Laetrile Study Result; DCCRC’s New Name: Div. Of Extramural Affairs

This article is from The Cancer Letter archive.

Vol. 04 No. 34 | August 25, 1978

Download PDF Visit The Full Archive

Related Articles

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

February 18, 2005

“Don’t Judge Me On a Snapshot In Time,” Broder Says In Responding To Criticisms By Cancer Centers

July 7, 1989

FEBT, For Pain Control, Shows Positive Results In Phase III

May 26, 2006

Alan Rabson Named NCI Deputy Director

August 11, 1995

DCT Board to Study Modifications Of Existing Cooperative Group System

June 13, 1986

Smoking Declines Among U.S. Teens, HHS Survey Finds.

January 18, 2002